Correlation Between Esperion Therapeutics and STATE
Specify exactly 2 symbols:
By analyzing existing cross correlation between Esperion Therapeutics and STATE STREET P, you can compare the effects of market volatilities on Esperion Therapeutics and STATE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of STATE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and STATE.
Diversification Opportunities for Esperion Therapeutics and STATE
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Esperion and STATE is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and STATE STREET P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on STATE STREET P and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with STATE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of STATE STREET P has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and STATE go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and STATE
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 4.69 times more return on investment than STATE. However, Esperion Therapeutics is 4.69 times more volatile than STATE STREET P. It trades about 0.29 of its potential returns per unit of risk. STATE STREET P is currently generating about -0.11 per unit of risk. If you would invest 252.00 in Esperion Therapeutics on September 10, 2024 and sell it today you would earn a total of 96.00 from holding Esperion Therapeutics or generate 38.1% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Esperion Therapeutics vs. STATE STREET P
Performance |
Timeline |
Esperion Therapeutics |
STATE STREET P |
Esperion Therapeutics and STATE Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Esperion Therapeutics and STATE
The main advantage of trading using opposite Esperion Therapeutics and STATE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, STATE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STATE will offset losses from the drop in STATE's long position.Esperion Therapeutics vs. Lifecore Biomedical | Esperion Therapeutics vs. Catalent | Esperion Therapeutics vs. Tilray Inc | Esperion Therapeutics vs. Organogenesis Holdings |
STATE vs. Apogee Enterprises | STATE vs. Yuexiu Transport Infrastructure | STATE vs. Sun Country Airlines | STATE vs. Zane Interactive Publishing |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |